|
Phase II Study of Eribulin Mesylate Administered Biweekly in Patients With Human Epidermal Growth Factor Receptor-2–negative Metastatic Breast Cancer |
|
|
|
Title: |
Phase II Study of Eribulin Mesylate Administered Biweekly in Patients With Human Epidermal Growth Factor Receptor-2–negative Metastatic Breast Cancer |
Author: |
Smith II, John Irwin, Amy Jensen, Lori Tedesco, Karen Misir, Soamnauth Zhu, Wei Almonte, Ana He, Yaohua Xie, Ran Olivo, Martin O’Shaughnessy, Joyce |
Appeared in: |
Clinical breast cancer |
Paging: |
Volume 20 () nr. 2 pages 160-167 |
Year: |
2020 |
Contents: |
|
Publisher: |
The Authors |
Source file: |
Elektronische Wetenschappelijke Tijdschriften |
|
|
|
|